News

Here are the latest TFRI news stories. See our archive for a full history of news.

  • November 24, 2014

    The Terry Fox Foundation is pleased to announce the appointment of Britt Andersen as its new Executive Director, effective November 24, 2014.

  • November 13, 2014

    The Terry Fox Foundation (TFF) is pleased to announce that Taiwan President Ma Ying-jeou will participate in the Terry Fox Run being held in Taipei, Taiwan on Saturday November 15, 2014.

  • November 05, 2014

    BC MLAs and ministers had an opportunity Nov. 3 to learn how cancer research is working from TFRI-BC Node Regional Advisory Committee members and invited speakers.

  • October 23, 2014

    Victoria, BC Oct. 23, 2014 -- BC legislature calls for the second Sunday after Labour Day to be designated Terry Fox Day

  • September 10, 2014

    Terry Fox Foundation takes aim at hard-to-treat cancers and personalized treatment with multimillion-dollar research investment at six leading Toronto cancer centres

  • August 15, 2014

    Dr. John Maris will deliver the opening address at this year's TFRI BC Node Research Day, taking place on 13 November at the BC Cancer Agency.

  • July 28, 2014

    TFRI’s fifth annual scientific meeting (ASM) in Montreal, Quebec this spring wrapped up with a surprise cash donation of a $1,000 for Terry Fox research.

  • March 06, 2014

    Three promising Canadian cancer researchers, two in Ontario and one in Quebec, have been awarded a total of $1.35 million under the Terry Fox Research Institute’s 2013 New Investigator Awards.

  • February 16, 2014

    Researchers funded by the Terry Fox Foundation and based at the BC Cancer Agency’s Centre for Lymphoid Cancer in Vancouver have discovered a new, recurrent genetic mutation in two kinds of lymphoma -- Hodgkin lymphoma and primary mediastinal B-cell lymphoma (PMBCL).

  • February 07, 2014

    TFRI’s efforts to improve outcomes for colorectal cancer patients received a vote of confidence this week with the announcement that a pan-Canadian initiative comprising colorectal researchers supported by TFRI, has been awarded $15-million from the federal government to establish a Business-Led Network of Centres of Excellence (BL-NCE) in Precision Therapeutics